EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Risk Management in the U.S. Pharmaceutical Industry: Supply, Manufacturing and Regulatory Resilience
US pharma risk management is the practice of identifying scoring and reducing threats to drug quality supply and compliance before they reach patients The strongest programs focus on three areas supply chain risk sourcing logistics shortages manufacturing risk quality contamination capacity and regulatory risk FDA inspections data integrity policy shifts They connect
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
AZP2006 in Parkinson’s disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex
The pathohistological hallmarks of Parkinsons disease are aggregated alphasynuclein and other aggregationprone proteins Lewy bodies Recent studies show mechanistic as well as genetic connections between lysosomal dysfunction and Parkinsons disease pathology A direct link between lysosomal function and Parkinsons disease might be the degradation of alphasynuclein within the lysosomal system
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Best Practices for Pharma HCP Engagement: Insights, Challenges, and Opportunities
Sarah Richards
Pharma HCP engagement is the establishment of effective, regulatory relationships between pharmaceutical firms and medical practitioners. Considerable interaction is associated with increased physicia...
-
2
Pharma Display Advertising: Boost Leads & Webinar Registrations Instantly
Kate Williamson
Pharma display advertising provides pharmaceutical organizations with a high level of targeting healthcare and industry audiences with the help of targeted digital placements. Through pharmaceutical d...
-
3
Navigating the Regulatory Landscape: Impact of Recent and Upcoming Changes on Pharma Businesses in the United States
Kate Williamson
This article explores the transformative regulatory landscape shaping the U.S. pharmaceutical industry. From FDA reforms and accelerated approvals to data integrity, drug pricing, digital health, supp...
-
4
Global Regulatory Harmonization Strategies for Multi-Region Drug Approvals
Kate Williamson
Integrating Multiregional drug approvals Global regulatory harmonization is simplifying drug approvals across the globe, harmonizing global standards, extending submissions, complicated the developmen...
-
5
Pharmaceutical Quality Systems in the U.S.: GMP, Quality Control and Manufacturing Compliance
Kate Williamson
Pharmaceutical quality systems are the backbone of safe medicines in the United States. This article explains how FDA cGMP regulations (21 CFR Parts 210 and 211) shape manufacturing, quality control,...
press releasesRead more...
Cemvita and Roebling Partner to Accelerate Industrial BioSolutions From Discovery to Deployment
Cemvita an emerging frontier AI lab for industrial BioSolutions today announced a partnership with Roebling an AInative engineering firm to speed the discovery evaluation and deployment of biological solutions for the naturalresource industries Cemvita brings more than a decade of experience develop...
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
Ambry Genetics a leader in clinical genomic testing and a wholly owned subsidiary of Tempus AI Inc today announced the launch of GenomeNext and GenomeReveal a comprehensive whole genome sequencing WGS solution designed to help improve diagnosis
Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop Sec61-Targeting Small Molecules
Enodia Therapeutics a biotechnology company developing novel smallmolecule therapies for targeted protein degradation at the point of synthesis today announced it has entered into a research collaboration and license agreement with Pfizer
OpenEvidence and Johns Hopkins Medicine Announce Landmark Collaboration to Design the Future of Medicine and Medical Education in the Age of AI
OpenEvidence the most popular AI for doctors in the United States today announced a strategic collaboration with Johns Hopkins Medicine JHM to reimagine medical education and clinical care in the age of artificial intelligence The collaboration spans two foundational pillars preparing the next gener...
Events Read more...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
27 - 28
Oct 2026PM& AC 2026
Novotel Hyderabad Convention C...
28 - 30
Oct 2026BIOPLUS-INTERPHEX Korea
COEX, Seoul
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
LATEST NEWSRead more...
Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications
Lkahi Therapeutics a subsidiary of Glucotrack Inc today announced the public launch of Qare a comparative health platform designed to help users compare selfreported treatment experiences across medications within the same therapeutic class Launching initially in the GLP category Qare enables
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
Pulse Biosciences Inc the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation nanoPFA or nsPFA technology today announced a partnership with the Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa Florida The partnership covers both the comme...
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
Agilent Technologies Inc announced it has entered into a definitive agreement to acquire Proscia a provider of digital pathology software for clinical and lifesciences customers in an allcash transaction valued at million in cash at closing and up to an additional
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
Charles River Laboratories International Inc and Magellan Stem Cells a private Australian biotech and celltherapy firm announce their collaboration to support Magellan in the development and clinical advancement of its proprietary stem cellbased therapies and regenerative medicine solutions The part...
Medicinal Genomics Launches Next-Day Pathogen Testing for Dietary Supplements
Medicinal Genomics today launched a rapid microbial testing solution for dietary supplement manufacturers that delivers nextday pathogen results compared with the three to five days typical of USP culture methods The solution includes three PathoSEEK
Americhem Opens New Clean Compounding Facility in Suzhou, China
Americhem a global leader in custom polymer solutions celebrated the opening of its new clean compounding facility in Suzhou on September The investment expands Americhems ability to support customers in China across AsiaPacific and around the world who manufacture in the region
